Axim Biotechnologies

(OTC: AXIM)
Healthcare  |  Biotechnology
0.62 -0.0001 -0.02%
Stock Price | Sept. 25, 2020, 3:59 p.m.
0 Followers
Bid: 0.595
Ask: 0.625
Prev. Close: 0.625
52 Week Low: 0.1
52 Week High: 1.44
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Axim Biotechnologies Inc is a vertically integrated research and development company. It is focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). AXIM's NeuCovixTM is the rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. The firm is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis.

Read more Read less

Recently Viewed Tickers

Premium Mid-Week Chat

3 years ago

Premium Mid-Week Chat

3 years ago

Premium Bull Market in Bogus Cannabis Companies

13 Comments
3 years ago

Premium Cannabis Stocks Review - AM Edition 01/13/17

4 Comments
3 years ago

Premium Review of 30 Companies Not on the Focus List

24 Comments
3 years ago